Related Experiment Video
Updated: Jun 4, 2026
07:08
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
Pdx1 expression in pancreatic precursor lesions and neoplasms
Jason Y Park1, Seung-Mo Hong, David S Klimstra
1Department of Pathology, University of Texas Southwestern Medical Center, Dallas, 75235, USA. jaspar@childrens.com
Applied Immunohistochemistry & Molecular Morphology : AIMM
|February 8, 2011
Summary
Pancreatic and duodenal homeobox (Pdx1) protein is found in various pancreatic tumors and precursor lesions, not just pancreatic endocrine neoplasms and ductal adenocarcinomas. This study reveals Pdx1 expression in pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and other neoplasms.
Area of Science:
- Oncology
- Molecular Biology
- Gastroenterology
Background:
- Pancreatic and duodenal homeobox (Pdx1) is crucial for pancreas development.
- Pdx1 expression is known in pancreatic ductal adenocarcinomas and endocrine neoplasms.
- Its role in precursor lesions and other pancreatic neoplasms requires further characterization.
Purpose of the Study:
- To characterize Pdx1 protein expression in a wide range of pancreatic precursor lesions and neoplasms.
- To determine if Pdx1 expression is specific to certain pancreatic tumor types.
Main Methods:
- Utilized a mouse monoclonal antibody for Pdx1.
- Examined >655 tissue cores from over 250 pancreatic specimens using immunohistochemistry.
- Scored nuclear labeling for Pdx1 based on percentage and intensity.
Main Results:
- Pdx1 was expressed in non-neoplastic islet cells, centroacinar cells, and ductal epithelium, but not acinar cells.
- Consistent Pdx1 labeling (>50% tumor cells) observed in 87.5% of acinar cell carcinomas (ACC) and 38.6% of pancreatic endocrine neoplasms (PEN).
- Variable Pdx1 expression found in invasive ductal adenocarcinoma, PanIN, IPMN, MCN, and pancreatoblastoma; absent in solid pseudopapillary neoplasms.
Conclusions:
- Pdx1 expression is present in precursor lesions (PanIN, IPMN, MCN) and various pancreatic neoplasms, including ACC and pancreatoblastoma.
- Pdx1 is not specific to pancreatic endocrine neoplasms or ductal adenocarcinomas.
- Immunohistochemical evaluation of pancreatic neoplasms should consider Pdx1 expression in a broader context beyond PENs and adenocarcinomas.
